A groundbreaker in the engineering of natural cosmetic active ingredients, SILAB is currently focusing on the markets of dermo-cosmetics and dermatology. SILAB softcare relies on SILAB's expertise, capacity for innovation and responsive organization to broaden acquired knowledge of healthy skin to the problems of compromised skin.
For over five years, a team of multidisciplinary researchers, made up of molecular biologists, bioinformaticians, clinical experts and process engineers, has been deploying cutting-edge tools and advanced technologies from the healthcare sector to hone its knowledge of cutaneous ecosystems. It has designed an original scientific research program, comprising innovative in vitro and in vivo models approved by the international dermatological community, to offer a product in the form of a preservative-free powder, revolving around three principles of excellence: Efficacy, Safety and Naturality.
SILAB softcare's first development phase has resulted in the marketing of AD-RESYL®, a patented natural active ingredient dedicated to the comfort and resilience of atopic skin. This product prevents the clinical signs of atopic dermatitis by prolonging remission periods following treatment with corticosteroid therapy. Tested on cohorts of Caucasian and Asian children and/or adults, AD-RESYL® meets the many expectations of patients on the lookout for care and comfort to restore health to their skin: it benefits from clinically demonstrated efficacy, optimum skin tolerance, and a controlled natural raw material.
SILAB is an independent French group whose development is based on a strategy of organic growth. Our innovations for the beauty and care of healthy skin have been recognized worldwide for 30 years and our expertise in the area of cutaneous biology is naturally driving us to broaden our sphere of research to include compromised skin. This new department has many ambitions and other research projects have already been launched (acne, healing, etc.) explains Brigitte CLOSS-GONTHIER, Deputy Managing Director for Research, SILAB.
Key figures regarding the first research theme: atopic dermatitis
- 5 years of research
- 15 dedicated researchers
- 11 high-level scientific publications